Stimulants are the best first-line medication for ADHD
Methylphenidate or amphetamines (including lisdexamfetamine) should be your first choice for treating ADHD, as they demonstrate the largest effect sizes (approximately 1.0) for reducing core ADHD symptoms and have rapid onset of action. 1
Why Stimulants Are Superior
The evidence is clear and consistent across multiple guidelines:
- Effect size advantage: Stimulants achieve effect sizes of approximately 1.0 compared to placebo, while non-stimulants (atomoxetine, guanfacine, clonidine) only reach effect sizes of 0.7 2
- Rapid onset: Stimulants work immediately, whereas atomoxetine requires 6-12 weeks and alpha-2 agonists need 2-4 weeks to show effects 1
- Robust efficacy: Multiple head-to-head trials confirm stimulants outperform non-stimulants 1
Choosing Between Stimulants
Start with methylphenidate as it has the most extensive evidence base and multiple formulation options (immediate-release, various extended-release preparations, chewable tablets, liquid, transdermal patches) that allow individualized dosing schedules 1
If methylphenidate fails after adequate trial (appropriate dosage and duration), switch to lisdexamfetamine as your next stimulant option before considering non-stimulants 1
Both methylphenidate and amphetamines work through dopamine and norepinephrine reuptake inhibition, with amphetamines additionally promoting neurotransmitter release 1
When to Consider Non-Stimulants Instead
Non-stimulants should be first-line only in these specific scenarios 1:
- Comorbid substance use disorders (risk of stimulant diversion/abuse)
- Comorbid tic disorders or Tourette's syndrome
- Severe disruptive behavior disorders
- Comorbid sleep disorders (where stimulant-induced insomnia would worsen the condition)
- Patient/family preference for non-controlled substances
Critical Monitoring Parameters
For stimulants, monitor 1:
- Height and weight (growth velocity may decrease 1-2 cm, though effects diminish by year 3)
- Blood pressure and pulse (expect mild increases)
- Sleep patterns (insomnia is common)
- Appetite (decreased appetite is the most frequent side effect)
Common Pitfalls to Avoid
Don't abandon stimulants after one trial: If methylphenidate doesn't work, try an amphetamine preparation before switching to non-stimulants 1
Don't underdose: Use adequate doses and duration before declaring treatment failure 1
Don't forget formulation flexibility: Extended-release formulations provide all-day coverage and reduce rebound symptoms in afternoon/evening 1
Preschool exception: For ages 4-5 years, behavioral therapy should be attempted first, with stimulants reserved for moderate-to-severe cases that don't respond to behavioral interventions alone 2
The Bottom Line Algorithm
- First choice: Methylphenidate (preferably extended-release for convenience and compliance)
- Second choice: Lisdexamfetamine or other amphetamine if methylphenidate inadequate
- Third choice: Non-stimulants (atomoxetine, guanfacine, clonidine) only after stimulant trials fail OR if specific comorbidities/contraindications exist
The evidence consistently shows stimulants provide superior symptom control, faster onset, and better functional outcomes compared to all other medication options 1.